Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Chelsea's hypotension drug fails to prove efficacy past week one
Reuters
Wednesday, December 5, 2012 - 10:17am
tags:
Chelsea Therapeutics, hypotension
FDA Gives More Time to Generic Facilities to Register, Saying Many Have Not
Regulatory Affairs Professionals Society
Wednesday, December 5, 2012 - 10:16am
tags:
generics, FDA
India's Strides Arcolab, Eli Lilly in generic cancer drug tie-up
Reuters
Wednesday, December 5, 2012 - 10:14am
tags:
India, Eli Lilly, generics, Strides Arcolab
1 Huge Courtroom Win for Pharma
Motley Fool
Wednesday, December 5, 2012 - 10:08am
tags:
off-label, whistleblower lawsuits
Pfizer's Post-2012 View Remains Void Of Necessary Catalysts
Seeking Alpha
Wednesday, December 5, 2012 - 10:07am
tags:
Pfizer
Big Pharma Sees More Approvals, Disappointing Revenues: Healthcare Business Update
Wall St. Cheat Sheet
Wednesday, December 5, 2012 - 10:06am
tags:
drug approvals, Pfizer, Merck, GSK, Sanofi, Roche
Merck Must Face Trial on Pregnancy Bias Claims
Courthouse News
Tuesday, December 4, 2012 - 1:42pm
tags:
Merck, gender discrimination
Geron ends brain cancer drug study, cuts 43 jobs
Yahoo/AP
Tuesday, December 4, 2012 - 1:41pm
tags:
Geron, brain cancer, layoffs, GRN1005
Drugmakers Nudged by FDA to Find Childhood Cancer Cures
Bloomberg
Tuesday, December 4, 2012 - 1:39pm
tags:
FDA, cancer, pediatric cancer
The Road Toward Far-Reaching Therapeutics Through Illumina, Sarepta
Seeking Alpha
Tuesday, December 4, 2012 - 1:36pm
tags:
Sarepta, Illumina, Life Technologies, Exelixis
Amicus: Bullish Options Trade Into Clinical Trial Catalysts
TheStreet.com
Tuesday, December 4, 2012 - 1:36pm
tags:
Amicus, clinical trials, Amigal
Biotech's Comeback Kid
Forbes
Tuesday, December 4, 2012 - 1:35pm
tags:
Biogen Idec, George Scangos, Genentech
ImmunoGen's Press Release Is More Than Mere News
Seeking Alpha
Tuesday, December 4, 2012 - 1:33pm
tags:
Immunogen, Targeted Antibody Payload
NPS Pharma Drifts Higher On Potential Orphan Drug Approval
Seeking Alpha
Tuesday, December 4, 2012 - 1:33pm
tags:
NPS Pharmaceuticals, orphan drugs, short bowel syndrome, Gattex
Drug industry treading water on R&D productivity
Reuters
Tuesday, December 4, 2012 - 12:10pm
tags:
R&D
Are Allergan and Orexigen Warming Up?
Motley Fool
Tuesday, December 4, 2012 - 12:09pm
tags:
Allergan, Orexigen
Forest Labs Sued By Doctor For Sending Junk Faxes
Pharmalot
Tuesday, December 4, 2012 - 12:02pm
tags:
Forest Labs, physicians
Sucampo Drops After FDA Delays Amitiza Decision
Bloomberg
Tuesday, December 4, 2012 - 12:01pm
tags:
FDA, Sucampo, Amitiza
Baxter Agrees to Buy Sweden’s Gambro for $4 Billion
Bloomberg
Tuesday, December 4, 2012 - 11:59am
tags:
Baxter, Sweden, Gambro, M&A
U.S. Barred From Prosecuting Off-Label Sales of Drugs
Bloomberg
Tuesday, December 4, 2012 - 11:57am
tags:
off-label

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.